Can the UK be an independent leading regulator in the development of new medicines and medical devices?

The Chequers summit on 6 July and the subsequent resignation of ministers illustrates how controversial it is to decide whether the UK should share a “common rule book” with the EU after Brexit, or set up its own independent regulators. In this blog, Derek Hill looks at the regulation of medicines and medical devices as examples of the thin margin of action that the UK … Continue reading Can the UK be an independent leading regulator in the development of new medicines and medical devices?

EU referendum: the view of a UCL clinician-scientist

John Martin, Professor of Cardiovascular Medicine at UCL, argues that scientific advance relies on creativity, cooperation, and financing. To leave the EU would diminish all three, dimming the light of British science in the world and threatening the UK’s future economy. This piece is part of the UCL European Institute’s commissioning partnership with openDemocracy. For more on this topic, join the UCL European Institute for its high-level panel discussion EU Membership and UK Science on 12 May. Continue reading EU referendum: the view of a UCL clinician-scientist